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Objective: This study examines racial/ethnic differences in the prevalence, patterns, and correlates of co-
occurring substance use and mental disorders (COD) among Whites, Blacks, Latinos, and Asians using data 
from the Collaborative Psychiatric Epidemiology Studies. Method: We first estimated the prevalence of various 
combinations of different co-occurring depressive and anxiety disorders among respondents with alcohol, drug, 
and any substance use (alcohol or drug) disorders in each racial/ethnic group. We then estimated the 
prevalence of different patterns of onset and different psychosocial correlates among individuals with COD of 
different racial/ethnic groups. We used weighted linear and logistic regression analysis controlling for key 
demographics to test the effect of race/ethnicity. Tests of differences between specific racial/ethnic subgroups 
were only conducted if the overall test of race was significant. Results: Rates of COD varied significantly by 
race/ethnicity. Approximately 8.2% of Whites, 5.4% of Blacks, 5.8% of Latinos, 2.1% of Asians met criteria for 
lifetime COD. Whites were more likely than persons in each of the other groups to have lifetime COD. 
Irrespective of race/ethnicity, the majority of those with COD reported that symptoms of mental disorders 
occurred before symptoms of substance use disorders. Only rates of unemployment and history of psychiatric 
hospitalization among individuals with COD were found to vary significantly by racial/ethnic group. 
Conclusions: Our findings underscore the need to further examine the factors underlying differences between 
minority and non-minority individuals with COD as well as how these differences might affect help seeking and 
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The problem of co-occurring substance use and mental disorders (COD) is common. The largest study 
of co-occurring disorders to date, the National Epidemiologic Survey on Alcohol and Related Conditions 
(NESARC), found that approximately 20% of all persons in the general population with a current substance use 
disorder had at least one current independent (i.e., non-substance-induced) mood disorder, and 18% had at 
least one current independent anxiety disorder (1, 2). Individuals with COD tend to be worse off than those with 
substance use or mental disorders alone on a variety of dimensions (3-6).  Persons with COD have been found 
to suffer from poor health (7-10), high unemployment (9), unstable housing (10, 11), and a history of suicide 
attempts (12). Despite heightened awareness and guidelines for treatment (13, 14), many with COD fail to 
receive appropriate care (9, 15).  
Racial and ethnic minorities represent a growing segment of the US population, currently accounting for 
28% and 16% of the US population, respectively. More than half of the increase in the US population from 
2000 to 2010 was a result of the increase in number of Latinos (i.e., individuals identifying as Hispanic or 
Latino). With a 43% increase from 2000 to 2010, Asians represent the fastest growing racial population in the 
US (16). Unfortunately, research has consistently shown that racial/ethnic minorities face greater barriers to 
care than non-minorities (17, 18) and are more likely to underutilize mental health services (19, 20).  
 These disparities in care may leave racial/ethnic minorities with COD particularly vulnerable. 
Unfortunately, research on racial/ethnic differences among individuals with COD is sparse. Studies of the 
prevalence and co-occurrence of substance use and independent mood and anxiety disorders using the 
NESARC data indicate that co-occurring disorders are pervasive among all racial/ethnic subgroups and that 
dramatic differences exist among certain racial and ethnic subgroups (21). For example, Huang et al. (22) 
found that the association between alcohol and drug disorders and any mood disorders among Blacks was 
stronger than among Whites.  
 Research is also limited in identifying differences in the temporal ordering and correlates of COD 
among different racial/ethnic groups, knowledge which may yield important clues about the factors underlying 
differences in the prevalence of COD and could lead to more informed treatment for various racial/ethnic 
groups. Most of our knowledge about the temporal ordering in the general population comes from the NESARC 
study and the National Comorbidity Survey (NCS) (23). Unfortunately research from these studies is limited in 
that it has heretofore considered only certain disorders, such as alcohol dependence and social anxiety 
disorders (24), cannabis dependence and mental disorders (25), marijuana use and major depressive 
episodes (26), and has not specifically examined differences among various racial/ethnic groups (24-27). 
This study examines racial/ethnic differences in the prevalence, patterns, and correlates of COD using 
data from the Collaborative Psychiatric Epidemiology Studies (CPES). The CPES is comprised of three 
surveys: the National Comorbidity Survey Replication (NCS-R) (28), the National Study of American Life 
(NSAL) (29), and the National Latino and Asian American Study (NLAAS) (30). To date, only one study from 
the CPES has addressed the prevalence and patterns of COD (31), and it was limited to Latinos participating 
in the NLAAS study. The information gathered from this study is critical to guiding future research on the 




The CPES collected data on the prevalence of mental and substance use disorders, associated 
impairments, and treatment patterns from representative samples of majority and racial/ethnic minority adults 
in the US (32). CPES data was collected by the Survey Research Center of the Institute for Social Research 
(ICPSR) at the University of Michigan. The public use data set (33) was accessed through the ICPSR website 
and used in accordance to terms and conditions of a standard Restricted Data Use Agreement. 
 
Participants and Data Collection 
Participants were recruited using two sampling methods: (1) core sampling based on multi-stage 
stratified area probability designs, resulting in a nationally representative household sample; and (2) high-
density supplemental sampling to oversample Census block groups for target ancestry groups (e.g., Afro-
Caribbean, Chinese, Filipino, Vietnamese and Puerto Rican). The NCS-R was administered in two parts. Part I 
included all respondents (n=9,282). To reduce respondent burden, Part II, which included assessments of risk 
factors, consequences, correlates, and additional disorders, was administered to 5,692 respondents, 
oversampling those with clinically significant disorders (28).  
The full CPES sample included data from 20,013 adults ages 18 years or older who resided in any of 
the 50 states and Washington, DC. The final response rates for the surveys were: 70.9% (NCS-R), 72.3% 
(NSAL), and 73.2% (NLAAS). A total of 284 respondents in this study identified as an “Other” race and were 
not included in our analyses. The NCS-R sample consisted of 6,696 Whites, 1,230 Blacks, 883 Latinos and 
189 Asians. The NSAL sample consisted of 3,570 African Americans, 1,621 Blacks of Caribbean ancestry, and 
891 Whites (35). The NLAAS Latino sample consisted of 868 Mexicans, 495 Puerto Ricans, 577 Cubans and 
614 ‘other’ Latinos (36). The NLAAS Asian sample consisted of 600 Chinese, 508 Filipinos, 520 Vietnamese, 
and 467 ‘other’ Asians (37).  Table 1 lists weighted demographic characteristics for CPES respondents by 
race/ethnicity.  
 
INSERT TABLE 1 ABOUT HERE 
 
Interviews were conducted face-to-face or by telephone using a computer-assisted instrument between 
February 2001 and December 2003 (35, 37, 38). When requested, NLAAS interviews were conducted in the 
respondent’s native language (Spanish, Chinese, Tagalog or Vietnamese) (37, 38). Written informed consent 
was obtained from all participants in their preferred languages, and study procedures and protocols were 
approved by the Internal Review Boards of Cambridge Health Alliance, the University of Washington, the 
University of Michigan, and Harvard Medical School (35, 37-39).  
  
Instruments and Measures 
The core CPES questionnaire used across studies was adapted from the World Health Organization's 
(WHO) expanded version of the Composite International Diagnostic Interview (CIDI) developed for the World 
Mental Health (WMH) Survey initiative (40). The WMH-CIDI is a fully-structured, lay-administered diagnostic 
interview that generates DSM-IV diagnoses. In addition to the core diagnostics, each study also assessed key 
socio-demographic characteristics and impairments associated with these disorders.  
  The present analyses focus on lifetime substance use (alcohol and drug abuse or dependence), mood 
(major depressive episode or dysthymic disorder), and anxiety disorders (agoraphobia without panic, panic 
disorder, generalized anxiety disorder, social phobia, or posttraumatic stress disorder). We define history of 
COD as any lifetime alcohol or drug abuse or dependence AND any lifetime mental disorder (mood or anxiety 
disorder). This definition has been used in other studies using the CPES data (31). Substance use and 
posttraumatic stress disorders were not assessed among Whites in the NSAL study. In total, we could not 
determine COD status for 891 Whites, 188 Blacks, and 5 Latinos, all participants in the NSAL study.  
  Age of onset (AOO) for disorders in the WMH-CIDI is determined based on separate probes for the age 
at which symptoms for each disorder began. AOO variables for substance use and mental disorders were 
created by using the earliest age of onset for each type of disorder. We define different patterns of co-occurring 
disorders based on when the disorders began. Temporally primary substance use disorder is defined as any 
substance use disorder onset predating any mental disorder onset by more than a year; temporally secondary 
substance use disorders is defined as any mental disorder onset predating any substance use disorder onset 
by more than a year; temporally co-occurring disorders is defined as the onset of substance abuse and mental 
disorders within one year of each other. 
  To examine differences in psychosocial impairment among individuals with COD of different 
racial/ethnic groups, we created variables to measure poor physical health status, current unemployment, and 
difficulty paying bills as well as history of attempted suicide and psychiatric hospitalization. Poor health was 
defined as a response of “poor” on a 4-point scale ranging from excellent to poor. We dichotomized the CPES 
work status variable to denote being currently unemployed (versus employed or not in the workforce).  
Responses of bill paying being “extremely difficult”, “very difficult”, or “somewhat difficult” were used to create a 
dichotomous variable reflecting difficulty paying bills. 
  Psychiatric severity was assessed based on history of suicide attempts and psychiatric hospitalization. 
Respondents were coded as having a history of attempted suicide if they had ever attempted suicide; 
respondents who had thought about suicide but never attempted or never seriously thought about suicide were 
considered not to have a history of attempted suicide. Respondents with a particular disorder were asked 
whether they had ever been hospitalized for that disorder. Individuals who answered affirmatively  to that 
question or  who reported being admitted for an overnight stay in a hospital or other facility to receive help for 
problems with emotions, nerves, mental health, use of alcohol or drugs were considered to have a history of 
psychiatric hospitalization.  
 
Analyses   
We first estimated the overall prevalence of co-occurring disorders and the prevalence of various 
combinations of different co-occurring depressive and anxiety disorders among respondents with alcohol, drug, 
and any substance use (alcohol or drug) disorders in each racial/ethnic group. We then estimated the 
prevalence of different patterns of onset of substance use and mental disorders among respondents in each 
racial/ethnic group. Finally, we estimated the prevalence of different psychosocial correlates among individuals 
with COD of different racial/ethnic groups. Differences among racial/ethnic groups were tested using logistic 
and linear regression (White used as the reference category). All regression models adjusted for gender, age, 
marital status, income, education, and region as these characteristics vary by race/ethnicity and have been 
included in models in similar studies (21, 22). To reduce Type 1 error rates, tests of differences between 
racial/ethnic subgroups were conducted only if the overall effect of race was significant (adjusted Wald test 
with p<0.05). Because the CPES studies employed complex sampling methods, we used weighting corrections 
to adjust for probabilities of selection under the different components of the sampling design (34). Because our 
analyses included NCS-R study Part II variables, we used the CPES long weight. All analyses were conducted 
in Stata version 11 (41). Detailed tables are available from the corresponding author. 
 
Results 
 The overall prevalence of any lifetime substance use and any lifetime mental disorder was 7.3%; 
approximately 8.2% of Whites, 5.4% of Blacks, 5.8% of Latinos, 2.1% of Asians met criteria for a lifetime 
substance use and lifetime mental disorder. The likelihood of lifetime COD varied significantly by race/ethnicity. 
Whites were more likely than Blacks (OR=2.2, p<0.001), Latinos (OR=2.4, p<0.001), and Asians (OR=5.2, 
p<0.001) to have lifetime COD. Blacks and Latinos were each more likely than Asians to have lifetime COD 
(OR=2.6, p=0.004; OR=3.0, p<0.001, respectively).  
Table 2 indicates the prevalence of various mental disorders among those with alcohol, drug, and any 
substance use disorders. Among those with lifetime alcohol disorders, race/ethnicity was associated with 
differences in the likelihood of having any life time depressive disorder, a major depressive episode, and any 
anxiety disorder. Whites with a history of alcohol disorders were more likely than Blacks to have had any co-
occurring depressive disorder (OR=1.8, p<0.001), a major depressive episode (OR=1.8, p<0.001), and any 
anxiety disorder (OR=1.5, p=0.007).  
 
INSERT TABLE 2 ABOUT HERE 
 
Among those with any lifetime drug disorder, race/ethnicity was associated with differences in having 
had any life time depressive disorder, a major depressive episode, dysthymic disorder, agoraphobia, and 
social phobia. Whites with lifetime drug disorders were more likely than Blacks and Latinos to have had any 
depressive disorder (OR=1.8, p=0.004; OR=1.7, p=0.041, respectively) and a major depressive episode 
(OR=1.8, p=0.004; OR=1.7, p=0.042, respectively).  Whites and Latinos were less likely than Asians to have 
lifetime dysthymic disorder (OR=0.4, p=0.027; OR=0.2, p=0.004, respectively).  Whites were less likely than 
Asians to have had agoraphobia (OR=0.1, p=0.004) but were more likely than Blacks to have had social 
phobia (OR=1.8, p=0.009).  
Among those with any substance use disorder, race/ethnicity was associated with differences in having 
had any life time depressive disorder, a major depressive episode, any anxiety disorder, social phobia, and any 
mental disorder. Whites with any substance use disorders were more likely to have had these disorders than 
Blacks (OR=1.9, p<0.001; OR=1.9, p<0.001; OR=1.6 p=0.003; OR=1.8, p=0.002; OR=1.6, p=0.002). Whites 
were also more likely than Latinos to have had any lifetime anxiety disorder (OR=1.5, p=0.022).  
 
INSERT TABLE 3 ABOUT HERE 
 
Table 3 presents findings with respect to age of onset of substance abuse and mental disorders and 
temporal ordering of disorders among individuals with COD. Irrespective of race/ethnicity, the majority of those 
with COD reported that symptoms of mental disorders occurred before symptoms of substance use disorders. 
Temporal ordering of disorders did not vary by race/ethnicity; however, average age-of-onset for substance 
use disorders did. Average age of onset for substance use disorders was younger for Whites than for Blacks 
(B=-1.8, p=.001).  
INSERT TABLE 4 ABOUT HERE 
 
Table 4 presents the prevalence of various psychosocial impairments by race/ethnicity. Only rates of 
unemployment and history of psychiatric hospitalization were found to vary significantly by racial/ethnic group. 
Whites with COD were less likely than Blacks (OR=0.2, p<0.001), Latinos (OR=0.3, p=0.002), and Asians 
(OR=0.1, p=0.014) to be unemployed. Whites were more likely than Blacks to report ever staying of night in a 
hospital for psychiatric problems (OR=2.0, p=0.018). Blacks were less likely than Latinos to report ever staying 
of night in a hospital for psychiatric problems (OR=0.4, p=0.033).  
 
Discussion  
Our results indicate COD were generally more common among Whites. An important exception to this 
finding occurred among individuals with drug disorders. Asians with a history of drug disorders were more likely 
than Whites and Latinos to have had dysthymic disorder; they were also more likely than Whites to have had 
agoraphobia. Our results differ from those of Huang et al. (22) in that we found differences in the likelihood of 
co-occurring anxiety disorders by race/ethnicity where they did not, and we found that the association between 
substance use and mood disorders among Whites was stronger than among Blacks. 
 There are several differences between the NESARC and the CPES studies that complicate 
comparisons. First, our rates reflect the lifetime prevalence of COD while comparable studies from the 
NESARC study have examined the prevalence of “current” or past-12 month disorders. Our decision to use 
lifetime criteria as opposed to current was partly practical (to increase power) but mostly because we were also 
investigating average AOO of mental and substance use disorders and related psychosocial impairments, and 
similar studies examining onset and temporal sequencing of COD used lifetime prevalence criteria (27, 31).  
 The NESARC and CPES studies also used different instruments to assess psychiatric diagnoses. The 
NESARC study used the Alcoholism Alcohol Use Disorder and Associated Disabilities Interview Schedule–
DSM-IV Version (AUDADIS-IV) (42), which was developed to better differentiate between independent and 
substance-induced disorders. Although the WMH-CIDI asks respondents if they thought their mood or anxiety 
disorder was due to drinking or drug use, this approach has been criticized as differing from the intent and the 
specific definitions provided in the DSM-IV (43). It is possible that the potential lack of differentiation between 
independent and substance-induced disorders could lead to inflated rates of non-substance use disorders in 
particular and inflated rates of COD more generally. However, an additional criticism of the WMH-CIDI is that 
respondents skip the alcohol and drug dependence questions if responses to questions on abuse are all 
negative, which could lead to an undercounting of individuals who could potentially meet criteria for 
dependence and not abuse (44) and therefore an undercounting of individuals with COD.  
Finally, in their analysis of the NESARC data, Huang et al. (22) controlled for sex, age, income, marital 
status, education, region, and urbanicity. Our analyses controlled for all of these variables except urbanicity 
because the CPES data contained no comparable proxy measure. Including urbanicity may have highlighted 
greater disparities among minorities groups, as research suggests that rural minorities lag behind rural Whites 
and urban minorities on many crucial economic and social measures (45). However, our findings that Whites 
with substance use disorders were, in general, more likely than their minority counterparts to have various co-
occurring mental disorders is similar to what Vega et al. (31) found in their analysis of the NLAAS data and to 
what Compton et al. (46) found in their study of differences between Whites and Blacks with substance 
dependence and other psychiatric disorders in drug treatment. 
Our findings regarding Asians are notable because racial/ethnic minorities are more likely to experience 
greater disability from mental disorders due to receipt of less care and poorer quality of care (47-50). Asians 
may face unique barriers due to beliefs about the causes of psychiatric disorders and attitudes toward helping 
professionals (51-54).  In their study of receipt of services among Asian, Native Hawaiian/Other Pacific 
Islander (NHOPI) and White mothers, Ta et al. (20) found that Asians and NHOPI were significantly less likely 
than Whites to have ever received mental health and substance abuse treatment. The reasons underlying 
differential risk for COD among racial/ethnic groups raises important questions regarding the influence of 
culture on psychopathology and how these differences may affect treatment seeking and use of psychiatric 
services. 
Irrespective of race/ethnicity, the majority of individuals with COD reported that symptoms of mental 
disorders occurred before symptoms of substance use disorders. This finding is consistent with other studies 
showing that mental disorders typically begin at earlier ages (55-57) and predict subsequent onset of 
substance use disorders (58-61). Although simulation studies have found that treatment of mental disorders 
would not be cost-effective in preventing substance use disorders (62), our findings lend further evidence to 
suggest that prevention of substance use disorders should be considered an important secondary outcome of 
treatment for early onset mental disorders. We also found that average AOO for substance use disorders was 
younger for Whites than for Blacks; further work is needed to identify factors that may explain these 
differences.  
Individuals with COD tend to be worse off than those with substance use or mental disorders alone. We 
found that Blacks, Latinos, and Asians with COD were more likely to be unemployed than Whites. 
Unemployment rates are typically higher among minorities (63, 64), and having a COD may make them even 
more vulnerable. We also found that Whites and Latinos with COD were more likely than Blacks to report a 
history of psychiatric hospitalization. Although we intended history of psychiatric hospitalization to be an 
indicator of psychiatric severity, it may reflect differential help seeking or access to services. Further work 
needs to be done to sort out the two, particularly given research that suggests that perceived stigma may 
prevent Blacks from accessing mental health services (65, 66) and that Blacks with COD are more likely to 
receive substance abuse rather than mental health treatment (67, 68). 
In addition to the aforementioned limitations, several others should be noted as well. The CPES studies 
are cross-sectional and psychiatric diagnoses are based on self-reported symptoms. The lack of longitudinal 
data as well as self-presentation bias and recall error limit the interpretation of our findings, particularly with 
respect to temporal ordering of substance use and mental disorders. Further, our AOO variable was 
determined based probes for the age at which symptoms for each disorder began, which may not reflect the 
age at which the disorder first manifest.  It is also important to note that although we did examine temporal 
ordering, our definition of co-occurring disorders was not restricted to the temporally co-occurring disorders. 
Finally, although the CPES studies oversampled key racial/ethnic minority groups, the subsample of Asians 
with COD was relatively small and may have limited detection of differences between Asians and other 
racial/ethnic groups.  
Despite these limitations, this study is the first we could find to examine differences in temporal ordering 
and biopsychosocial impairments among individuals with COD of varying racial/ethnic groups in the general 
population. Our results indicate that rates of COD vary by race/ethnicity and highlight that ”minorities” are not a 
homogeneous group and that rates of COD vary depending on the type of substance use disorder (alcohol v. 
drug) and type of mental disorder (mood v. anxiety) considered. Future studies are need to better understand 
the nature of these differences and how they may affect help seeking and service use among individuals with 
COD in general and among minorities in particular. Such research is critical to developing culturally-sensitive 
prevention and treatment programs for racial/ethnic minorities with COD. 
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